Psychometric Study of Praxilene

Naftidrofuryl (Praxilene) has been shown experimentally to improve the metabolism of brain cells where this has been impaired by advancing ischaemia due to arteriosclerosis. It has been evaluated in warded chronic patients showing signs of impaired intellectual ability. The trial was performed double-blind involving an identical placebo and the results assessed using psychometric tests and analyzed statistically. The results confirm the effectiveness of Naftidrofuryl (Praxilene) in improving intellectual performance and this was particularly apparent in the less severely affected.